Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Lucid Stock Still Looks Like a Bargain Here as Its EV Production Ramps up in 2022

By Mark R. Hake, CFA

Lucid stock still looks like a bargain here as its EV Production ramps up in 2022. LCID stock looks cheap here given that it trades for about 8 times adj. forward sales and has enough cash to ramp up EV production.

Why Recent Delivery Figures Are Important for Nio Stock

By Mark R. Hake, CFA

Nio stock looks cheap for investors here as long as the company hits its revenue and profit forecasts in the next two years.

Matterport Is in the Bargain Bin Despite Its Excellent Growth Prospects

By Mark R. Hake, CFA

Investing in MTTR stock causes near-term pain for long-term gain as the company builds out its subscription sales.

Microsoft’s All Cash Acquisition of Activision Blizzard Is a Good Use of its Cash

By Mark R. Hake, CFA

The Activision deal looks great for MSFT stock as it will have synergistic benefits for both companies.

Novavax Is Worth 77% More Over the Next 2 Years

By Mark R. Hake, CFA

When comparing its value to competitor Moderna, NVAX stock can reach $164 by 2024 using probability assessments to adjust for risk.

Load More